Search results
Results from the WOW.Com Content Network
Sirolimus, also known as rapamycin and sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumour (PEComa).
Sirolimus (rapamycin, trade name Rapamune) is a macrolide lactone, produced by the actinomycete bacterium Streptomyces hygroscopicus. It is used to prevent rejection reactions. Although it is a structural analogue of tacrolimus, it acts somewhat differently and has different side-effects.
An anti-rejection-type medication, sirolimus, helps to limit the overgrowth of normal cells while the artery heals which reduces the chance of re-blockage in the treated area known as restenosis, and reduces the chances that another procedure is required. [1] [2] The Cypher stent was approved for use by the FDA in 2003. [2]
For premium support please call: 800-290-4726 more ways to reach us
Everolimus, sold under the brand name Afinitor among others, is a medication used as an immunosuppressant to prevent rejection of organ transplants [10] and as a targeted therapy in the treatment of renal cell cancer and other tumours.
In the first two months of 2016 alone, Caroline Nosal and Janese Talton-Jackson were both murdered in the US by men whose advances they declined. These 14 women were brutally attacked for ...
Umirolimus (INN/USAN, also called Biolimus) is an immunosuppressant, a macrocyclic lactone, a highly lipophilic derivative of sirolimus.This drug is proprietary to Biosensors International, which uses it in its own drug-eluting stents, and licenses it to partners such as Terumo.
College Admissions 2013: Record Rejection Rates, Financial Aid Uncertainty and Waitlist Limbo Mean April Angst for Many Students and Parents Available for Interview: A Kaplan Test Prep Expert Can ...